November 18, 2026
Health news, explained with evidence
LIVE

American Cancer Society Issues New Guidelines Recommending Routine Prostate Cancer Screening

❤️ Conditions & Care 2 min read 👁 9

The American Cancer Society has updated its guidelines to recommend routine prostate-specific antigen blood tests every two years for men aged 50 to 69, marking a notable shift in screening policy.

American Cancer Society Issues New Guidelines Recommending Routine Prostate Cancer Screening❤️Conditions & Care

Photo: The New York Times Health

Key points

  • ACS recommends biennial P.S.A. screening for men aged 50 to 69.
  • Black men and those with a family history are advised to start annual screening at age 45.
  • Experts caution that routine screening could still lead to unnecessary biopsies and treatment harms.

The American Cancer Society (ACS) has released updated guidance advising that all men between the ages of 50 and 69 undergo regular prostate cancer screening every two years using a blood test. Under the new recommendations, Black men and individuals with a strong family history of the disease should begin annual screenings at age 45, reflecting significant health disparities in diagnoses and mortality rates.

This update represents a departure from earlier advice that left the decision entirely up to individual patients and physicians following a discussion of risks and benefits. Universal screening for prostate cancer has historically sparked debate due to the limitations of prostate-specific antigen (P.S.A.) testing and the potential harms of diagnosing slow-growing tumors that may never threaten a patient's life. While the ACS points to long-term European trial data showing a modest reduction in prostate cancer deaths and fewer metastatic cases, some clinical experts express concern that the new stance might encourage routine testing without adequate shared decision-making.

What to know: The updated ACS guidelines suggest biennial P.S.A. blood tests for men aged 50 to 69, and annual testing starting at age 45 for Black men or those with a strong family history. Although advocates cite modern diagnostic refinements like MRIs and active surveillance as ways to minimize harms, critics worry about the potential for over-testing and overtreatment. Readers should consult a qualified physician to discuss personal risk factors and make informed screening decisions.

Source The New York Times Health — nytimes.com/2026/11/12/well/prostate-cancer-screening-guideline.html ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.